Posts Tagged ‘asuragen’

symBIOsis event on December 1, 2009

Tuesday, November 24th, 2009

symBIOsis-1ATI is hosting a symBIOsis event on December 1, 2009 and here are the details.  If you are interested in the bio and life sciences community in Austin, this is the place to be.

Rice Alliance – Austin Chapter and UT’s Austin Technology Incubator
Invite you to attend the upcoming symBIOsis event.

The mission of symBIOsis is to provide an Austin-area forum
for the life sciences community to network, support each other, and
learn about the challenges of starting and growing life sciences technology companies.

Tuesday, December 1, 2009
5:30PM – 7:30PM
AT&T Executive Education & Conference Center
$5 Students, $15 General (before Dec 1)
https://www.registrationassistant.com/p/rg.asp?Event=3A05C35509FC593D73AA6

“Intellectual Property for Life Sciences Entrepreneurs”
Enjoy food, drink, & conversation with Austin’s life sciences network. Then stay for a panel discussion to learn more from the experts about how you and/or your startup should be thinking about Intellectual Property – it’s the heart of any life sciences company, but it’s not always given the strategic focus it requires.

Confirmed Panelists:
Kevin Lalande
Managing Director
Santé Ventures

Jack Richards, II
Patent Attorney
Trop, Pruner & Hu, P.C.

Ana Ward
Senior Vice President and General Counsel
Asuragen, Inc.

http://www.symbiosisaustin.org

Term Sheets and Valuations Session #3

Wednesday, November 4th, 2009

As part of our services to member companies we coordinate Lunch & Learns on various topics and recently we’ve been doing a 3 part series on term sheets and valuations.   Check out the speakers we had on the Term Sheets and Valuations Session #1 post and the key takeaways and speakers on Session #2.

The third was held on October 26 which we will be posting about soon.  The third session in the series on term sheets and valuations was a panel comprised of successful entrepreneurs.   They  shared their tips and tricks on getting financing rounds managed and closed as well as what terms are most important to them.

The following was written by Celeste Mejia, one of our ATI Interns, who previously interned with Goldman Sachs.  She  is currently working with member companies InXero, Unwired Nation, and Agile Planet.

Takeaways:

Some key mistakes entrepreneurs make when approaching VCs and discussing term sheets include:

  • Not paying attention to ownership and equity. Not being flexible in terms of percentage ownership.
  • Focusing too much on the pre-money value, when post-money value is often more important for VCs.
  • Being overly optimistic. Assume things will go badly and plan for that.

Tips for entrepreneurs:

  • The more entrepreneurs can control on the first round, the more options and leverage they will have on  further rounds
  • Understanding what “preferred stock” and “participating preferred stock” means is important. Typically, common stock will get very little money at exit.
  • Typical ownership that VCs ask for in Series A will range from 25% to 35%.
  • The employee stock pool shouldn’t be ignored. By exit, VCs will probably want to carve out the pool and it will be 100% dilutive to owners. Entrepreneurs should try to make that pool as small as they can.  Relative range: 20% or less if possible.  The employee pool is generally refreshed at each investment round.
  • Due to the state of the economy, there is a disconnect between what VC’s expect, in terms of return, and what they can realistically get. In order to compensate for this difference, VCs will ask for more ownership
  • Going to VC’s that have experience in your company’s field and striking a connection with them is very important
  • It takes a long time to secure A round financing. Typically, companies will speak to 30 or more VCs before meeting a match. Meeting frequently with VCs even if there’s no immediate need for money will help build important relationships.
  • Angels are a great place to go to get “enough traction” that leads to VC investing

Speakers:

David Altounian is the President and CEO of Motion Computing, a leading provider of Slate Tablet computing products.   He was the founding member of the Motion team and was a key product officer until 2006 when he left to pursue a graduate degree.  Mr. Altounian rejoined Motion in July of 2008.  Mr. Altounian has more than 20 years of management and staff experience in the technology sector. Retired from Dell Computer Corporation after nearly seven years, Mr. Altounian served in senior marketing executive positions for both the notebook computer and workstation product businesses where he was responsible for the Worldwide Product Marketing organizations. He spent two years in Europe as the General Manager, Workstation Line of Business for Europe, Middle East, and Africa.

Prior to joining Dell, Mr. Altounian managed marketing and business development teams for leading technology companies including Motorola, Compaq Computer Corporation and Ashton-Tate.  He was the founder and is currently a board member of iTaggit Inc., a web 2.0 company committed to helping people document, showcase, monetize, and value the things that they collect.     He earned his Bachelor of Science degree in business administration from California Coast University and earned his MBA at Kellogg School of Management at Northwestern University.

Ana C. Ward is currently Senior Vice President, General Counsel for Asuragen, Inc. Prior to Asuragen, she was General Counsel for Ambion and was responsible for a wide variety of legal issues including licensing, corporate transactions, patents, and trademarks. Prior to joining Ambion, Ms. Ward served as Senior Intellectual Property Counsel for Tricon Global Restaurants, Inc., and as an associate at the law firm Sidley & Austin. She has a BA in French/Zoology, a Masters in Molecular Biology, a Doctor of Jurisprudence, and a Masters of Business Administration, all from the University of Texas at Austin. Ms. Ward is also a registered patent attorney, and served as an adjunct professor at the UT School of Law.

Larry Warnock is the President & CEO of Phurnace Software, Inc., an ATI alumni company.  He provides strategic guidance and operational expertise to the company. Larry has over 25 years of experience working with start-up and established technology companies. Most recently he was CMO of Vignette, a publicly traded enterprise content management software company. As a Venture Partner at AV Labs (Austin Ventures), Larry assisted with the incubation of several early-stage software companies. Previously, he was an executive at start-up OnLink Technologies which was acquired by CRM market-leader Siebel Systems. Earlier in his career, Larry was a VP at Documentum, a publicly traded content-management software company (acquired by EMC) from its start-up phase through a successful IPO and into the market leader. Larry holds a BBA in Marketing from Texas A&M University where he was a Cadet Lt. Colonel in the Corps of Cadets. He is currently a guest lecturer at McCombs School of Business, University of Texas at Austin, and the Acton MBA program of Hardin-Simmons University.

Sponsored By:

AK TAGLINE_Grey_HiRes_VectorAndrews Kurth is a leading law firm for entrepreneurs, public and private emerging grown companies, and venture capital and private equity firms.  Our firm’s Technology & Emerging Growth practice comprises a dedicated team of attorneys in technology centers around the United States providing focused representation to public and private emerging growth companies and entrepreneurs as well as the venture capital and private equity firms that finance them.  We take pride in having a practical, business-life approach to advising our clients, and we share their entrepreneurial spirit and drive.  Our driven client service teams combine relevant experience with an understanding of a client’s business and markets to provide efficient, cost-effective legal services and creative solutions with an outstanding degree of responsiveness.  We thrive in the fast-paced entrepreneurial world by combining flexibility and speed with the experience that comes from taking billions of dollars in new ventures from inception to IPO and beyond.

ATI Launches symBIOsis

Wednesday, September 30th, 2009

The Rice Alliance-Austin Chapter has teamed up with the Bioscience program at the Austin Technology Incubator to launch symBIOsis

The term “symbiosis” is commonly used to describe close and often long-term interactions between different biological species. 

The vision for this new event – symBIOsis – will similarly provide a forum for Austin-area life sciences entrepreneurs to interact with each other, to network with each other, and to learn together about the challenges of starting and growing life sciences companies, here in Austin.  symBIOsis is open to the broad life sciences community in Austin, with hopes that technology entrepreneurs; UT-Austin graduate students, postdoctoral fellows and faculty; company executives; and others will participate and benefit. 

The kick-off symBIOsis event was held on Tuesday, September 22, from 5:30-7:30PM at the AT&T Executive Conference Center near UT-Austin’s main campus.  The first hour was full of great conversation, networking, and delicious snacks.  Members of the University of Texas community enjoyed the opportunity to meet members of Austin’s life sciences sector, and vice versa. 

The second hour of the evening featured a panel discussion entitled “From Bench to Boardroom: Commercializing Life Sciences Technology,” with three individuals with very interesting and inspirational career pathways.  All three are wonderful examples of how a PhD in science or engineering can prepare one for all kinds of experiences not only in academia, but also within the life sciences industry. 

The panelists included: 

Thomas Milner, PhD
Marion E. Forsman Centennial Professor in Engineering
Department of Biomedical Engineering, UT-Austin


Bill Williams, PhD
Johnson & Johnson Centennial Professor of Pharmaceutics
Division Head, Pharmaceutics, UT-Austin
Editor-in-chief, Drug Development and Industrial Pharmacy

Matt Winkler, PhD
Chief Executive Officer
Chief Scientific Officer
Asuragen, Inc. 

Jessica Hanover, PhD, Director, ATI-Bioscience, moderated the panel discussion.  The conversation was particularly interesting to the graduate students and academicians in the room, with great insights into different roles for scientists and engineers within life sciences companies, and how academicians like the panelists had been successful transitioning to, or overlapping with, the life sciences industry.

Stay tuned for upcoming plans for symBIOsis in the future – you can check for updates at our website www.symbiosisaustin.org.